American Society of Hematology

2018 Abstract Categories

Abstracts in the following categories were accepted for submission for the 2018 ASH Meeting on Lymphoma Biology.

  1. Genetic Mechanisms Underlying Lymphomagenesis
    Includes genetic driven mechanisms of pathogenesis involving lymphoid malignancies and encompasses recurrent somatic mutations and/or copy number alterations as well as heritable variation associated with lymphoma risk.
  2. Epigenetic Mechanisms in Leukemia and Lymphoma
    Includes epigenetic mechanisms that underlie leukemia and lymphoma pathogenesis and/or alterations to chromatic remodeling that contribute to lymphoma initiation and/or progression.
  3. Cell of Origin, Tumor Heterogeneity, and Microenvironmental Interactions
    Includes studies that focus on tumor clonal development, evolution, and intra-tumoral cellular heterogeneity involving infiltrating cells in lymphoid malignancies as well as novel strategies to dynamically and non-invasively monitor such evolution. This category also includes studies investigating the role of the tumor microenvironment in tumor biology and pathogenesis.
  4. Signaling Pathways in Leukemia and Lymphoma
    Includes primarily basic studies of signaling pathways associated with lymphomagenesis. Includes studies of the role of post-translational receptor modification, oncogenes, and tumor suppressor genes in cellular and mouse models as well as patients.
  5. Targeting Cell Survival
    Includes studies aimed at molecular understanding of essential survival pathways in lymphoma, including strategies for targeted therapeutic regimens.
  6. Immunotherapies for Lymphoid Cancers
    Includes studies employing novel therapies that target aspects of adaptive and innate immunity as part of their mechanism of action.
  7. Biological and Targeted Therapies in Lymphoid Malignancies
    Includes novel targeted treatment approaches to lymphoid malignancies, such as mechanism-based combination strategies, excluding immunotherapies.
  8. T-Cell Lymphomas and Rare Entities
    Includes primarily basic studies of T-cell lymphoproliferative diseases, lymphomas of infectious etiology, and other rare entities.
back to top